Acacia Pharma is a commercial stage biopharmaceuticall group focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy. The Group has identified important and commercially attractive unmet needs in nausea & vomiting and procedural sedation, and has two approved products and a late-stage development candidate in its portfolio designed to meet those needs.